August 2023
Washington, D.C. (August 30, 2023)— Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the Biden-Harris Administration's announcement that ten drugs will now be eligible for price negotiation under Medicare as a direct result of the Inflation Reduction Act:
Washington, D.C. (August 16, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the decision by the United States U.S. Fifth Circuit Court of Appeals to restrict access to the U.S. Food and Drug Administration's (FDA) approved abortion medication:
Washington, D.C. (August 16, 2023)—Today, Rep.
Washington, D.C. (August 14, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, released a statement following Committee Republicans' release of the full transcript from an interview the Committee conducted four weeks ago with a former FBI supervisory agent assigned to the Hunter Biden investigation:
| Washington, D.C. (August 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Attorney General Merrick Garland announced U.S. Attorney David Weiss's appointment as special counsel: |
Washington, D.C. (August 3, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, released a memo showing how Committee Republicans have grossly misrepresented the transcribed interview the Committee conducted with Devon Archer, Hunter Biden's former business associate.